Article information
Abstract
Valvular heart disease is a condition with increasing prevalence. Although the current treatment of choice is still valve repair or replacement surgery, percutaneous treatment techniques are valid alternatives for selected patients. Various non-invasive imaging techniques are currently available which can provide the information needed to select appropriate patients, planning procedures and techniques.
This article reviews the usefulness of cardiac CT to assess patients who are candidates for percutaneous treatment of common valvular diseases. It also reviews the image acquisition protocol and its role in the pre-procedural study, as well as in the detection of the most common complications.
Keywords:
Valvular heart disease
Valvulopathy
Cardiac CT
Percutaneous interventions
Resumen
La cardiopatía valvular es una entidad cuya prevalencia se encuentra en aumento. A pesar de que actualmente el tratamiento de elección continúa siendo la cirugía de reparación o reemplazo valvular, las técnicas de tratamiento percutáneo ofrecen una alternativa válida en pacientes seleccionados. Las distintas técnicas de imagen no invasivas de las que se dispone en la actualidad aportan la información necesaria para la correcta selección de estos pacientes y para la adecuada planificación del procedimiento y elección de la técnica apropiada.
En este artículo se revisa la utilidad de la cardio-TC en el estudio del paciente candidato a tratamiento percutáneo de las principales valvulopatías, el protocolo de adquisición de imagen, y su papel en el estudio pre-procedimiento, así como en la detección de las principales complicaciones.
Palabras clave:
Cardiopatía valvular
Valvulopatía
Cardio-TC
Intervencionismo percutáneo
Article
These are the options to access the full texts of the publication Radiología (English Edition)
Subscriber
Purchase
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
References
[1]
J.L. D’Arcy, S. Coffey, M.A. Loudon, A. Kennedy, J. Pearson-Stuttard, J. Birks, et al.
Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study.
Eur Heart J., 37 (2016), pp. 3515-3522a
[2]
V.T. Nkomo, J.M. Gardin, T.N. Skelton, J.S. Gottdiener, C.G. Scott, M. Enriquez-Sarano.
Burden of valvular heart diseases: a population-based study.
Lancet., 368 (2006), pp. 1005-1011
[3]
A. Vahanian, F. Beyersdorf, F. Praz, M. Milojevic, S. Baldus, J. Bauersachs, et al.
2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).
Rev Esp Cardiol (Engl Ed), 75 (2022), pp. 524
[4]
A. Jurado-Román, X. Freixa, B. Cid, I. Cruz-González.
Registro español de hemodinámica y cardiología intervencionista. XXXII informe oficial de la Asociación de Cardiología Intervencionista de la Sociedad Española de Cardiología (1990-2022).
Rev Española Cardiol, 76 (2023), pp. 1021-1031
[5]
T.C. Pulerwitz, O.K. Khalique, J. Leb, R.T. Hahn, T.M. Nazif, M.B. Leon, et al.
Optimizing cardiac CT protocols for comprehensive acquisition prior to percutaneous MV and TV repair/replacement.
JACC Cardiovasc Imaging., 13 (2020), pp. 836-850
[6]
N. Piazza, P. de Jaegere, C. Schultz, A.E. Becker, P.W. Serruys, R.H. Anderson.
Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve.
Circ Cardiovasc Interv., 1 (2008), pp. 74-81
[7]
P. Blanke, J.R. Weir-McCall, S. Achenbach, V. Delgado, J. Hausleiter, H. Jilaihawi, et al.
Computed tomography imaging in the context of transcatheter aortic valve implantation (TAVI) / transcatheter aortic valve replacement (TAVR): An expert consensus document of the Society of Cardiovascular Computed Tomography.
J Cardiovasc Comput Tomogr., 13 (2019), pp. 1-20
[8]
P. Pibarot, J.G. Dumesnil.
Low-flow, low-gradient aortic stenosis with normal and depressed left ventricular ejection fraction.
J Am Coll Cardiol., 60 (2012), pp. 1845-1853
[9]
J. Choe, H.J. Koo, S.J. Choi, S.A. Lee, D.H. Kim, J.M. Song, et al.
Differences in aortic valve area measured on cardiac CT and echocardiography in patients with aortic stenosis.
PLoS One., 18 (2023), pp. 1-14
[10]
M.A. Clavel, J. Malouf, D. Messika-Zeitoun, P.A. Araoz, H.I. Michelena, M. Enriquez-Sarano.
Aortic valve area calculation in aortic stenosis by CT and doppler echocardiography.
JACC Cardiovasc Imaging., 8 (2015), pp. 248-257
[11]
T. Pawade, M.A. Clavel, C. Tribouilloy, J. Dreyfus, T. Mathieu, L. Tastet, et al.
Computed tomography aortic valve calcium scoring in patients with aortic stenosis.
Circ Cardiovasc Imaging., 11 (2018), pp. 1-11
[12]
M.A. Clavel, D. Messika-Zeitoun, P. Pibarot, S.R. Aggarwal, J. Malouf, P.A. Araoz, et al.
The complex nature of discordant severe calcified aortic valve disease grading: New insights from combined Doppler echocardiographic and computed tomographic study.
J Am Coll Cardiol., 62 (2013), pp. 2329-2338
[13]
C. Cueff, J.M. Serfaty, C. Cimadevilla, J.P. Laissy, D. Himbert, F. Tubach, et al.
Measurement of aortic valve calcification using multislice computed tomography: Correlation with haemodynamic severity of aortic stenosis and clinical implication for patients with low ejection fraction.
Heart., 97 (2011), pp. 721-726
[14]
D. Messika-Zeitoun, M.C. Aubry, D. Detaint, L.F. Bielak, P.A. Peyser, P.F. Sheedy, et al.
Evaluation and clinical implications of aortic valve calcification measured by electron-beam computed tomography.
Circulation., 110 (2004), pp. 356-362
[15]
M.J. Mack, J.M. Brennan, R. Brindis, J. Carroll, F. Edwards, F. Grover, et al.
Outcomes following transcatheter aortic valve replacement in the United States.
Jama., 310 (2013), pp. 2069-2077
[16]
S.H. Yoon, S. Bleiziffer, O. De Backer, V. Delgado, T. Arai, J. Ziegelmueller, et al.
Outcomes in transcatheter aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis.
J Am Coll Cardiol., 69 (2017), pp. 2579-2589
[17]
D. Dvir, J. Leipsic, P. Blanke, H.B. Ribeiro, R. Kornowski, A. Pichard, et al.
Coronary obstruction in transcatheter aortic valve-in-valve implantation preprocedural evaluation, device selection, protection, and treatment.
Circ Cardiovasc Interv., 8 (2015), pp. 1-10
[18]
H.B. Ribeiro, L. Nombela-Franco, M. Urena, M. Mok, S. Pasian, D. Doyle, et al.
Coronary obstruction following transcatheter aortic valve implantation: A systematic review.
JACC Cardiovasc Interv., 6 (2013), pp. 452-461
[19]
H.B. Ribeiro, J.G. Webb, R.R. Makkar, M.G. Cohen, S.R. Kapadia, S. Kodali, et al.
Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: Insights from a large multicenter registry.
J Am Coll Cardiol., 62 (2013), pp. 1552-1562
[20]
P. Cepas-Guillén, R. Gabani, M. Giménez-Milà, L. Sanchis, X. Freixa, A. Regueiro.
Safety and efficacy of the BASILICA technique in patients at high risk of coronary obstruction undergoing TAVI.
Rev Esp Cardiol., 73 (2023), pp. 2-3
[21]
M. Barbanti, T.H. Yang, J. Rodès Cabau, C. Tamburino, D.A. Wood, H. Jilaihawi, et al.
Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement.
Circulation., 128 (2013), pp. 244-253
[22]
N.C. Hansson, J. Leipsic, F. Pugliese, H.R. Andersen, A. Rossi, M. Simonato, et al.
Aortic valve and left ventricular outflow tract calcium volume and distribution in transcatheter aortic valve replacement: Influence on the risk of significant paravalvular regurgitation.
J Cardiovasc Comput Tomogr., 12 (2018), pp. 290-297
[23]
S.H. Ewe, A.C.T. Ng, J.D. Schuijf, F. Van Der Kley, A. Colli, M. Palmen, et al.
Location and severity of aortic valve calcium and implications for aortic regurgitation after transcatheter aortic valve implantation.
Am J Cardiol., 108 (2011), pp. 1470-1477
[24]
L. Biasco, E. Ferrari, G. Pedrazzini, F. Faletra, T. Moccetti, F. Petracca, et al.
Access sites for TAVI: patient selection criteria, technical aspects, and outcomes.
Front Cardiovasc Med, 5 (2018), pp. 1-11
[25]
K. Okuyama, H. Jilaihawi, M. Kashif, N. Takahashi, T. Chakravarty, H. Pokhrel, et al.
Transfemoral access assessment for transcatheter aortic valve replacement: Evidence-based application of computed tomography over invasive angiography.
Circ Cardiovasc Imaging., 8 (2014), pp. 1-9
[26]
K. Hayashida, T. Lefvre, B. Chevalier, T. Hovasse, M. Romano, P. Garot, et al.
Transfemoral aortic valve implantation: new criteria to predict vascular complications.
JACC Cardiovasc Interv., 4 (2011), pp. 851-858
[27]
D. Dvir, T. Bourguignon, C.M. Otto, R.T. Hahn, R. Rosenhek, J.G. Webb, et al.
Standardized definition of structural valve degeneration for surgical and transcatheter bioprosthetic aortic valves.
Circulation., 137 (2018), pp. 388-399
[28]
A. Schaefer, T.J. Demal, O.D. Bhadra, D. Grundmann, L. Voigtländer, L. Waldschmidt, et al.
Valve-in-valve procedures for degenerated surgical and transcatheter aortic valve bioprostheses using a latest-generation self-expanding intra-annular transcatheter heart valve.
Front Cardiovasc Med., 10 (2023), pp. 1-8
[29]
H.B. Ribeiro, J. Rodés-Cabau, P. Blanke, J. Leipsic, J. Kwan Park, V. Bapat, et al.
Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: Insights from the VIVID registry.
Eur Heart J., 39 (2018), pp. 687-695
[30]
K. Goel, B.R. Lindman.
Hypoattenuated leaflet thickening after transcatheter aortic valve replacement: expanding the evidence base but questions remain.
Circ Cardiovasc Imaging., 12 (2019), pp. 10-13
[31]
M. Daĺen, U. Sartipy, K. Cederlund, A. Franco-Cereceda, A. Svensson, R. Themudo, et al.
Hypo-attenuated leaflet thickening and reduced leaflet motion in sutureless bioprosthetic aortic valves.
J Am Heart Assoc., 6 (2017),
[32]
S. Garcia, M. Fukui, M.W. Dworak, B.K. Okeson, R. Garberich, G. Hashimoto, et al.
Clinical impact of hypoattenuating leaflet thickening after transcatheter aortic valve replacement.
Circ Cardiovasc Interv., 15 (2022), pp. 303-312
[33]
S.V. Chheda, M.B. Srichai, R. Donnino, D.C. Kim, R.P. Lim, J.E. Jacobs.
Evaluation of the mitral and aortic valves with cardiac CT angiography.
J Thorac Imaging., 25 (2010), pp. 76-85
[34]
M. Shanks, V. Delgado, A.C.T. Ng, F. Van Der Kley, J.D. Schuijf, E. Boersma, et al.
Mitral valve morphology assessment: three-dimensional transesophageal echocardiography versus computed tomography.
Ann Thorac Surg., 90 (2010), pp. 1922-1929
[35]
P. Blanke, C. Naoum, J. Webb, D. Dvir, R.T. Hahn, P. Grayburn, et al.
Multimodality imaging in the context of transcatheter mitral valve replacement establishing consensus among modalities and disciplines.
JACC Cardiovasc Imaging., 8 (2015), pp. 1191-1208
[36]
P. Ranganath, A. Moore, M. Guerrero, J. Collins, T. Foley, E. Williamson, et al.
CT for pre-and postprocedural evaluation of transcatheter mitral valve replacement.
Radiographics., 40 (2020), pp. 1528-1553
[37]
V. Delgado, L.F. Tops, J.D. Schuijf, A. de Roos, J. Brugada, M.J. Schalij, et al.
Assessment of mitral valve anatomy and geometry with multislice computed tomography.
JACC Cardiovasc Imaging., 2 (2009), pp. 556-565
[38]
A. Palazzuoli, F. Cademartiri, M.L. Geleijnse, B. Meijboom, F. Pugliese, O. Soliman, et al.
Left ventricular remodelling and systolic function measurement with 64 multi-slice computed tomography versus second harmonic echocardiography in patients with coronary artery disease: a double blind study.
Eur J Radiol., 73 (2010), pp. 82-88
[39]
Y.K. Guo, Z.G. Yang, G. Ning, L. Rao, L. Dong, Y. Pen, et al.
Isolated mitral regurgitation: quantitative assessment with 64-section multidetector CT - Comparison with MR imaging and echocardiography.
Radiology., 252 (2009), pp. 369-376
[40]
P.J. Van Rosendael, S.E. Van Wijngaarden, V. Kamperidis, W.K.F. Kong, M. Leung, N.A. Marsan, et al.
Integrated imaging of echocardiography and computed tomography to grade mitral regurgitation severity in patients undergoing transcatheter aortic valve implantation.
Eur Heart J., 38 (2017), pp. 2221-2226
[41]
P. Blanke, D. Dvir, A. Cheung, J. Ye, R.A. Levine, B. Precious, et al.
A simplified D-shaped model of the mitral annulus to facilitate CT-based sizing before transcatheter mitral valve implantation.
J Cardiovasc Comput Tomogr., 8 (2014), pp. 459-467
[42]
M. Guerrero, M. Urena, D. Himbert, D.D. Wang, M. Eleid, S. Kodali, et al.
1-Year outcomes of transcatheter mitral valve replacement in patients with severe mitral annular calcification.
J Am Coll Cardiol., 71 (2018), pp. 1841-1853
[43]
S.H. Yoon, S. Bleiziffer, A. Latib, L. Eschenbach, M. Ancona, F. Vincent, et al.
Predictors of left ventricular outflow tract obstruction after transcatheter mitral valve replacement.
JACC Cardiovasc Interv., 12 (2019), pp. 182-193
[44]
D.D. Wang, M.H. Eng, A.B. Greenbaum, E. Myers, M. Forbes, P. Karabon, et al.
Validating a prediction modeling tool for left ventricular outflow tract (LVOT) obstruction after transcatheter mitral valve replacement (TMVR).
Catheter Cardiovasc Interv., 92 (2018), pp. 379-387
[45]
B.J. Gersh, B.J. Maron, R.O. Bonow, J.A. Dearani, M.A. Fifer, M.S. Link, et al.
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration with the American Ass.
J Am Coll Cardiol., 58 (2011), pp. 212-260
[46]
V.C. Babaliaros, A.B. Greenbaum, J.M. Khan, T. Rogers, D.D. Wang, M.H. Eng, et al.
Intentional percutaneous laceration of the anterior mitral leaflet to prevent outflow obstruction during transcatheter mitral valve replacement: first-in-human experience.
JACC Cardiovasc Interv., 10 (2017), pp. 798-809
[47]
V. Caruso, U. Shah, H. Sabry, I. Birdi.
Mitral valve annulus and circumflex artery: In vivo study of anatomical zones.
JTCVS Tech., 4 (2020), pp. 122-129
[48]
Y. Lu, Y. Yang, W. Wang, J. Chen, M. Yin, L. Huang, et al.
Transcatheter mitral valve-in-valve implantation with a new transcatheter heart valve for bioprosthetic degeneration.
Front Cardiovasc Med., 8 (2021),
[49]
S.H. Yoon, B.K. Whisenant, S. Bleiziffer, V. Delgado, N. Schofer, L. Eschenbach, et al.
Transcatheter mitral valve replacement for degenerated bioprosthetic valves and failed annuloplasty rings.
J Am Coll Cardiol., 70 (2017), pp. 1121-1131
[50]
F. Praz, O.K. Khalique, R. Lee, I.Y. Wu, H. Russell, M. Guerrero, et al.
Imaging in patients with severe mitral annular calcification: Insights from a multicentre experience using transatrial balloon-expandable valve replacement.
Eur Heart J Cardiovasc Imaging., 20 (2019), pp. 1395-1406
[51]
M. Guerrero, D.D. Wang, A. Pursnani, M. Eleid, O. Khalique, M. Urena, et al.
A Cardiac computed tomography–based score to categorize mitral annular calcification severity and predict valve embolization.
JACC Cardiovasc Imaging., 13 (2020), pp. 1945-1957
[52]
C.U. Meduri, M.J. Reardon, D.S. Lim, E. Howard, G. Dunnington, D.P. Lee, et al.
Novel multiphase assessment for predicting left ventricular outflow tract obstruction before transcatheter mitral valve replacement.
JACC Cardiovasc Interv., 12 (2019), pp. 2402-2412
[53]
M.F. Eleid, A.K. Cabalka, J.F. Malouf, S. Sanon, D.J. Hagler, C.S. Rihal.
Techniques and outcomes for the treatment of paravalvular leak.
Circ Cardiovasc Interv., 8 (2015), pp. 1-13
[54]
R.T. Hahn, L.T. Weckbach, T. Noack, N. Hamid, M. Kitamura, R. Bae, et al.
Proposal for a standard echocardiographic tricuspid valve nomenclature.
JACC Cardiovasc Imaging., 14 (2021), pp. 1299-1305
[55]
B.S. Ingraham, K.A. Young, P. Reddy, V. Anand, J.M. Stulak, C.S. Rihal, et al.
Analysis of cardiac computed tomography anatomy in patients with severe tricuspid regurgitation considered for transcatheter intervention.
Struct Hear., 7 (2023),
[56]
P.S. Rajiah, P. Reddy, V. Baliyan, S.S. Hedgire, T.A. Foley, E.E. Williamson, et al.
Utility of CT and MRI in tricuspid valve interventions.
Radiographics., 43 (2023),
[57]
W.A. Zoghbi, D. Adams, R.O. Bonow, M. Enriquez-Sarano, E. Foster, P.A. Grayburn, et al.
Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American society of echocardiography developed in collaboration with the society for cardiovascular magnetic resonance.
J Am Soc Echocardiogr., 30 (2017), pp. 303-371
[58]
R.T. Hahn, J.D. Thomas, O.K. Khalique, J.L. Cavalcante, F. Praz, W.A. Zoghbi.
Imaging assessment of tricuspid regurgitation severity.
JACC Cardiovasc Imaging., 12 (2019), pp. 469-490
[59]
H. Fu, X. Wang, K. Diao, S. Huang, H. Liu, Y. Gao, et al.
CT compared to MRI for functional evaluation of the right ventricle: a systematic review and meta-analysis.
Eur Radiol., 29 (2019), pp. 6816-6828
[60]
M.V.M. Dupont, C.A. Drǎgean, E.E. Coche.
Right ventricle function assessment by MDCT.
Am J Roentgenol., 196 (2011), pp. 77-86
[61]
J. Gelves-Meza, R.M. Lang, M.D. Valderrama-Achury, J.L. Zamorano, C. Vargas-Acevedo, H.M. Medina, et al.
Tricuspid regurgitation related to cardiac implantable electronic devices: an integrative review.
J Am Soc Echocardiogr., 35 (2022), pp. 1107-1122
[62]
M. Andreas, H. Burri, F. Praz, O. Soliman, L. Badano, M. Barreiro, et al.
Tricuspid valve disease and cardiac implantable electronic devices.
Eur Heart J., 45 (2024), pp. 346-365
[63]
F.F. Faletra, L.A. Leo, V.L. Paiocchi, S.A. Schlossbauer, M.G. Borruso, G. Pedrazzini, et al.
Imaging-based tricuspid valve anatomy by computed tomography, magnetic resonance imaging, two and three-dimensional echocardiography: Correlation with anatomic specimen.
Eur Heart J Cardiovasc Imaging., 20 (2019), pp. 1-13
[64]
F. Saremi, C. Hassani, V. Millan-Nunez, D. Sánchez-Quintana.
Imaging evaluation of tricuspid valve: analysis of morphology and function with CT and MRI.
Am J Roentgenol., 204 (2015), pp. W531-42
[65]
N.C. Wunderlich, M. Landendinger, M. Arnold, S. Achenbach, M.J. Swaans, R.J. Siegel, et al.
State-of-the-art review: anatomical and imaging considerations during transcatheter tricuspid valve repair using an annuloplasty approach.
Front Cardiovasc Med., 8 (2021), pp. 1-16
[66]
P. Lurz, R. Stephan von Bardeleben, M. Weber, M. Sitges, P. Sorajja, J. Hausleiter, et al.
Transcatheter edge-to-edge repair for treatment of tricuspid regurgitation.
J Am Coll Cardiol., 77 (2021), pp. 229-239
[67]
P.J. Van Rosendael, V. Kamperidis, W.K.F. Kong, A.R. Van Rosendael, F. Van Der Kley, N.A. Marsan, et al.
Computed tomography for planning transcatheter tricuspid valve therapy.
Eur Heart J., 38 (2017), pp. 665-674
[68]
S. Sanon, A.K. Cabalka, V. Babaliaros, C. Rihal, S. Gafoor, J. Webb, et al.
Transcatheter tricuspid valve-in-valve and valve-in-ring implantation for degenerated surgical prosthesis.
JACC Cardiovasc Interv., 12 (2019), pp. 1403-1412
[69]
O.A.J. Altisent, R. Benetis, E. Rumbinaite, V. Mizarien, P. Codina, F. Gual-Capllonch, et al.
Caval valve implantation (CAVI): An emerging therapy for treating severe tricuspid regurgitation.
J Clin Med., 10 (2021),
[70]
G. Costa, M. De Carlo, P. Spontoni, C. Giannini, M. Angelillis, L. Stazzoni, et al.
Heterotopic transcatheter tricuspid valve replacement in severe tricuspid regurgitation and refractory right heart failure.
JACC Case Rep., 4 (2022), pp. 1005-1011
[71]
H.L. Lindberg, K. Saatvedt, E. Seem, T. Hoel, S. Birkeland.
Single-center 50 years’ experience with surgical management of tetralogy of Fallot.
Eur J Cardio-Thoracic Surg., 40 (2011), pp. 538-542
[72]
H. Baumgartner, J. De Backer, S.V. Babu-Narayan, W. Budts, M. Chessa, G.P. Diller, et al.
Guía ESC 2020 para el tratamiento de las cardiopatías congénitas del adulto.
Rev Esp Cardiol, 74 (2021), pp. 436.e1-436.e79
[73]
A. Canan, D. Ocazionez-Trujillo, D. Vargas, T.A. Foley, A.K. Cabalka, P.S. Rajiah.
Pre-and postprocedure imaging of transcatheter pulmonary valve implantation.
Radiographics., 42 (2022), pp. 991-1011
[74]
M. Tezza, M. Witsenburg.
Nieman K, van de Woestijne PC, Budde RPJ. Cardiac CT to assess the risk of coronary compression in patients evaluated for percutaneous pulmonary valve implantation.
Eur J Radiol., 110 (2019), pp. 88-96
[75]
B.H. Morray, D.B. McElhinney, J.P. Cheatham, E.M. Zahn, D.P. Berman, P.M. Sullivan, et al.
Risk of coronary artery compression among patients referred for transcatheter pulmonary valve implantation a multicenter experience.
Circ Cardiovasc Interv., 6 (2013), pp. 535-542
